Liquidia Corp. (LQDA)

NASDAQHealth CareMedical - PharmaceuticalsSnapshot 2026-09-04

$68.66+0.04%

Close 2026-09-04 · 1-day change

QuarterlyIQ Insights · LQDA

Financials

Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.

Income Statement

Period

View

Order

Figures in millions of None, except per-share and ratios.

	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenues
Revenues	450.9	158.3	14.0	17.5	15.9	12.9	0.7
Cost of Revenues	—	—	5.9	2.9	2.9	3.0	0.2
Operating Expenses & Income
Selling, General & Admin	192.7	157.2	—	44.7	—	—	—
R&D Expenses	56.0	39.3	47.8	43.2	19.4	20.5	32.2
Operating Income	168.6	(51.4)	(121.3)	(73.4)	(38.8)	(33.8)	(59.1)
Earnings from Continuing Operations
Interest Expense	—	24.2	12.5	6.3	2.3	0.8	0.9
Interest & Investment Income	7.6	6.6	7.7	3.5	1.1	0.0	0.2
Net Interest Expenses	—	—	—	2.8	1.2	0.7	0.7
Other Non-Operating Income / Expenses	(19.1)	(17.5)	(9.1)	(5.1)	(2.2)	(0.8)	(0.7)
Income Tax Expense	—	—	—	0.0	0.0	0.0	0.0
Net Income
Net Income	138.6	(68.9)	(130.4)	(78.5)	(41.0)	(34.6)	(59.8)
Per Share
Basic EPS	1.56	(0.80)	(1.66)	(1.21)	(0.67)	(0.70)	(1.76)
Diluted EPS	1.37	(0.80)	(1.66)	(1.21)	(0.67)	(0.70)	(1.76)
Revenue per Share	4.45	—	—	—	—	—	—
Basic Weighted Avg Shares	88.9	86.1	78.7	65.0	61.0	49.7	33.9
Diluted Weighted Avg Shares	101.4	86.1	78.7	65.0	61.0	49.7	33.9
Supplemental
EBITDA	—	(50.5)	(120.5)	(72.2)	(37.4)	(32.0)	(56.2)
EBIT	168.6	(51.4)	(121.3)	(73.4)	(38.8)	(33.8)	(59.1)

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.